Fitzsimon_menu

Innovation is happening. Right here.

Fitzsimons Innovation Community is a sprawling campus of leading-edge laboratory workspace where innovative health and life sciences companies of all sizes take their research to the next level to cure diseases, save lives, and improve care.

Smart, inclusive, forward-thinking, and highly educated people lead life sciences innovation in Colorado, the Hub for Health Impact. Together, we welcome life sciences organizations looking to call Colorado home and to collaborate with a robust community already in on the secret: the health and life sciences industry in Colorado is strong and making a global impact on the future of health.

 Move in, and build your vision here—today.

Community

The emphasis is on Community

We called it a community for a reason. From the board of directors to the newest company on campus, everyone at Fitzsimons Innovation Community knows that easy access to collaboration has direct results on success. From idea incubation to final-product manufacturing, your end-to-end innovation can come alive right here on our campus. All that Colorado sunshine is just a bonus.

Community

Cutting-edge discoveries in action

62%

Companies Hiring

Fitzsimons Innovation Community member companies are thriving. 62% of companies added employees to their workforce.

75%

Companies Fundraising

Most Fitzsimons Innovation Community member companies are actively involved in fundraising to power their progress.

16+

New Innovations

Fitzsimons Innovation Community member companies introduced more than 16 new innovations to the market in 2023.

$116M

Capital Raised

Last year, Fitzsimons Innovation Community member companies attracted more than $116M in investments to support R&D, prepare for clinical trials, accelerate commercialization, and retain or recruit talent.

75%

Companies with Discoveries

Fitzsimons Innovation Community member companies made news with major breakthrough discoveries last year. Areas included molecular biology, pharmaceuticals, medical device, research tools, cell and gene therapy, material science, and diagnostics.

50%

Companies Forging Strategic Partnerships

Fitzsimons Innovation Community member companies forged strategic partnerships for business collaboration, legal services, and venture capital opportunities.

*Fitzsimons Innovation Community Member Growth Survey responses (January – December 2023)

A heritage of healthcare and innovation

Fitzsimons Innovation Community stands on the grounds that once held the Fitzsimons Army Hospital, where soldiers returning from World War I were treated. The Colorado high altitude has always been a destination for advancements in lung treatment, and 100 years ago, soldiers sought cures for tuberculosis and mustard gas exposure right here.

After the Army decommissioned the hospital in the 1990s, ideas for the current University of Colorado Anschutz Medical Campus and Fitzsimons Innovation Community began to percolate. That rich history of discovery, care, and research continues to inspire our vision a century later.

Our team is on your team

You know best when it comes to your projects, and we know how to keep you up and running with first-class scientific facilities management and community engagement. Our priority is to help you thrive on this campus and we have the proven tools and expertise to make that happen.

Bruce Schmidt

Chief Engineer

Don Larson

Facilities engineer

Juliena Carlson

Property Administrator

Julie Ehler

Controller

Kelly Brough

President & CEO

Kenneth Ho

Chief Operating Officer

Laurie Troge

Chief of Staff

Lyle Artz

Site manager

Sue Niblo

Senior property manager

“The workspace has been perfect for our projects, but the most impressive thing to me has been the community. We’ve collaborated with researchers from the CU Anschutz Medical Campus, networked with other Fitzsimons Innovation Community members, and bounced ideas off some of the best minds in healthcare. And it’s all contributed to us moving forward in our research.”

Scott Deeter

CEO, InVitria

“I park my car in the morning, and then I never move it until I leave after work. We walk to lunch and meetings and take advantage of the outdoor space as much as we can during the day. Work-life balance happens right on campus.”

Kristin Nixon

President, PhosphoSolutions

Community

Fitzsimons Innovation Community News

Onconaut Secures a Fast-Track STTR Grant from NIH/NCI
News | Aug 28, 2025

Onconaut Secures a Fast-Track STTR Grant from NIH/NCI

Onconaut Therapeutics, a privately-held therapeutics company and prior Innosphere client company, has received $2.5M in funding through a Fast-Track Small Business Technology Transfer (STTR) grant from the National Institute of Health, National Cancer Institute (NCI) for Onconaut to develop small molecule drug inhibitor targeting Chromodomain Helicase DNA binding protein (CHD1L), a novel oncogenic target for metastatic colorectal cancer and other cancers. The grant will allow Onconaut to rapidly develop a lead compound suitable for preclinical IND studies as a single agent and in combination with FOLFIRI.

NatGeo Spotlights CU Anschutz Research
News | Aug 20, 2025

NatGeo Spotlights CU Anschutz Research

National Geographic spotlighted groundbreaking research led by CU Anschutz experts, uncovering how COVID-19 and the flu may awaken dormant cancer cells. This discovery raises important questions for survivor care and demonstrates how Colorado researchers are advancing knowledge that impacts lives worldwide.

Fitzsimons Innovation Community's New Master Plan Approved
News | Aug 10, 2025

Fitzsimons Innovation Community's New Master Plan Approved

Fitzsimons Innovation Community Chief Operating Officer Kenneth Ho on the set of AuroraNow discussing the newly approved Master Plan, and how Fitzsimons plans to soften the edges of the campus through internship programs with local schools, community art installations, and other initiatives.

New Cancer Therapy Clings to Bladder Tumors, With Inspiration from Gecko Toes
News | Aug 09, 2025

New Cancer Therapy Clings to Bladder Tumors, With Inspiration from Gecko Toes

Researchers from University of Colorado Anschutz Medical Campus and University of Colorado Boulder have developed a gecko-inspired material that clings to bladder cancer tumors and slowly releases chemotherapy, introducing a promising new approach that could reduce the need for repeat treatments.

5280 Magazine Top Doctors for 2025 Includes 610 CU School of Medicine Faculty Members
News | Aug 08, 2025

5280 Magazine Top Doctors for 2025 Includes 610 CU School of Medicine Faculty Members

Denver’s 5280 Magazine has released its list of 2025 Top Doctors, and an incredible 610 University of Colorado School of Medicine faculty members earned the honor. University of Colorado Anschutz Medical Campus physicians continue to be recognized among the best across 75 specialties, congratulations to all who were honored this year!

Aurora Approves Thousands of New Housing Units for Life Sciences District
News | Aug 07, 2025

Aurora Approves Thousands of New Housing Units for Life Sciences District

Aurora City Council has approved a major residential expansion within the Fitzsimons Innovation Community, unlocking the potential for up to 7266 new housing units across the 184-acre campus. The development will support the area's growing life sciences hub, which is anchored by the CU Anschutz Medical Campus, and includes plans for mixed-use zones, residential-only areas, and improved infrastructure. With a minimum height of 4 stories for new buildings, the project aims to create a vibrant, walkable neighborhood that integrates seamlessly with the district’s cutting-edge research and medical facilities. Construction is expected to begin following resolution of final technical reviews.

CU Anschutz Research: Respiratory Viruses Can Wake Up Breast Cancer Cells in Lungs
News | Aug 06, 2025

CU Anschutz Research: Respiratory Viruses Can Wake Up Breast Cancer Cells in Lungs

Researchers at the University of Colorado Anschutz Medical Campus, Montefiore Einstein Comprehensive Cancer Center (MECCC) and Utrecht University have found the first direct evidence that common respiratory infections, including COVID-19 and influenza, can awaken dormant breast cancer cells that have spread to the lungs, setting the stage for new metastatic tumors. The findings were published in Nature.

A Potential Universal Target for Autoimmune: Q&A with Richard Freed
News | Aug 04, 2025

A Potential Universal Target for Autoimmune: Q&A with Richard Freed

Pharmaceutical Executive recently spoke with RheumaGen CEO Richard Freed about his career and the work the biotech is doing to find cures for autoimmune diseases.

9News Business Buzz: Aurora Approves Expansion of Fitzsimons Innovation Community
News | Jul 22, 2025

9News Business Buzz: Aurora Approves Expansion of Fitzsimons Innovation Community

Colorado Real Estate Journal features perspectives from Fitzsimons Innovation Community CEO, Kelly Jean Brough, in the Health Care and Life Sciences Quarterly. The article highlights 25 years of impact and what’s next for the transformation of the campus.

Healthy Future: Fitzsimons Looks to Next 25 Years
News | Jul 21, 2025

Healthy Future: Fitzsimons Looks to Next 25 Years

Colorado Real Estate Journal features perspectives from Fitzsimons Innovation Community CEO, Kelly Jean Brough, in the Health Care and Life Sciences Quarterly. The article highlights 25 years of impact and what’s next for the transformation of the campus.

Want to stay on top of what’s happening on campus?

Sign up for regular updates from Fitzsimons Innovation Community.